Financial & Business News

ROOT's investment income, fueled by fixed-income securities, bolsters earnings and underwriting strength amid shifting rate cycles.

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS ) Baird Global Healthcare Conference September 9, 2025 10:15 AM EDT Company Participants Cedric Francois - Co-Founder, President, CEO & Director Timothy Sullivan - CFO & Treasurer Conference Call Participants Colleen Hanley - Robert W. Baird & Co. Incorporated, Research Division Presentation Colleen Hanley Senior Research Analyst Right.

NEW YORK--(BUSINESS WIRE)--If you have suffered a loss on your SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE:SLQT) investment, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until October 10, 2025 to ask the Court to appoint them as lead plaintiff. [CONTACT THE FIRM IF YOU SUFFERED A LOSS] What Happened? O.

COLM drives growth with its ACCELERATE strategy, brand revamp and rising consumer engagement.

NEW YORK, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Fly-E Group, Inc. (“Fly-E” or the “Company”) (NASDAQ: FLYE) between July 15, 2025 and August 14, 2025, inclusive.

MongoDB is finally benefiting from the AI software adoption cycle, with its Atlas cloud product seeing strong demand from AI-native startups. Atlas posted 29% year-over-year revenue growth, but overall revenue guidance is tempered by a decline in non-Atlas, on-premise business. The market reacted positively, with shares up 38% after the report (plus more), recognizing the shift toward cloud and AI despite headline guidance appearing soft.

Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

NEW YORK , Sept. 9, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neogen Corporation (NASDAQ: NEOG) between January 5, 2023 and June 3, 2025 (the "Class Period"), of the important September 16, 2025 lead plaintiff deadline.

Panama City, Republic of Panama--(Newsfile Corp. - September 9, 2025) - Autris (OTCID: AUTR), ("Autris" or "the Company"), a pioneering company dedicated to promoting freedom and self-sustainability, through the acquisition, design, development, and construction of self-sustainable communities throughout Latin America and the Caribbean, is pleased to announce that it has been invited to present on the Emerging Growth Conference on September 25th, 2025. Autris invites individual and institutional investors as well as advisors and analysts to attend its real-time, interactive presentation at the Emerging Growth Conference.

ATLANTA, Sept. 09, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Biohaven Ltd. (“Biohaven” or the “Company”) (NYSE: BHVN). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information regarding Biohaven's business, operations, and prospects, including allegations that: (i) troriluzole's regulatory prospects as a treatment for spinocerebellar ataxia, and/or the sufficiency of data that Biohaven submitted in support of troriluzole's regulatory approval for this indication, were overstated; (ii) BHV-7000's efficacy and clinical prospects as a treatment for bipolar disorder were likewise overstated; and (iii) all of the foregoing, once revealed, was likely to have a significant negative impact on Biohaven's business and financial condition.